BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li SC, Shao SZ, Zhang YH, Zhou Y, Shang WT, Gao Y, He QB, Guo QL, Guo CY, Zhang XB. Wogonin derivative V8 enhances bortezomib efficacy in gastric carcinoma by disrupting lysosome-mediated drug resistance. World J Gastroenterol 2026; 32(8): 113299 [PMID: 41809875 DOI: 10.3748/wjg.v32.i8.113299]
URL: https://www.wjgnet.com/1007-9327/full/v32/i8/113299.htm
Number Citing Articles
1
Wen-Wen Liu, Xiao-Jun Yang. Letter to the Editor: Lysosomal vulnerability as a therapeutic axis for overcoming proteasome inhibitor resistance in gastric cancerWorld Journal of Gastroenterology 2026; 32(33): 118835 doi: 10.3748/wjg.118835